Home Health Care & Hospice M&A Rising, According to New M&A Report from Irving Levin Associates
|FOR IMMEDIATE RELEASE||
Stephen M. Monroe, Editor
NORWALK, CT – October 10, 2012 – The most significant recent year for Home Health Care & Hospice M&A activity was 2010, when the dollar value of transactions spiked in the second quarter of that year—the result of Gentiva acquiring Odyssey HealthCare for $984 million, combined with Highland Capital acquiring American HomePatient for $235.2 million, according to Irving Levin Associates’ new report The Home Health Care & Hospice Acquisition Report, Fourth Edition, 2012. Those two acquisitions, along with one in the first quarter of 2012, were unusually large, as deals valued at $30-60 million are otherwise considered quite large for this sector.
The number of transactions each year from 2009 through the second quarter of 2012 and respective annual dollar volume, according to The Home Health Care and Hospice Acquisition Report, Fourth Edition, 2012, are listed in the table below.
While the five Home Health Care & Hospice sector deals announced in the second quarter of 2012 amounted to less than half the number (11) announced in the previous quarter, the overall level of activity is on track to beat or at least match the number of transactions announced throughout 2011 (29). Last year the deals were fairly evenly split in terms of timing, with 13 transactions announced in the first half of the year and 16 in the second half.
The Home Health Care & Hospice Acquisition Report, Fourth Edition, 2012 is published by Irving Levin Associates, Inc. The new 2012 edition includes hard-to-find details on Home Health Care & Hospice M&A transactions such as price/revenue ratios, a therapeutic focus addressed by pharma targets and more. The report was recently published and can be purchased at http://www.levinassociates.com/home-health-description.